N-Nitroso Bendamustine

Status: Under Development

N-Nitroso Bendamustine or 4-(5-((2-chloroethyl)(nitroso)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid, is an antineoplastic agent is a class of nitrogen mustard drug that used for the treatment of chronic lymphocytic leukemia

Additional information on N-Nitroso Bendamustine

Catalogue No. VE008451
Molecular Formula C14H17ClN4O3
Molecular Weight 324.8 g/mol
Parent drug Bendamustine
IUPAC Name 4-(5-((2-chloroethyl)(nitroso)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid
Synonyms N/A
References Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia By Martina Bogelji? Patekar Container: Acta Clinica Croatica Year: 2018 DOI: 10.20471/acc.2018.57.03.18 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536274/
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

N-Nitroso Bendamustine

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.